Primary Pancreatic Burkitt’s Lymphoma: A Case Report and Review of the Literature

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:27.12em"/><col style="width:18.45em"/></colgroup><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Antibody</td><td class="align_center">Result</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">CD10 (M; 56C6; DAKO)</td><td class="align_center">Positive in lesional cells</td></tr><tr><td class="align_left">CD20 (M; L26; Vector)</td><td class="align_center">Positive in lesional cells</td></tr><tr><td class="align_left">CD3 (P; DAKO)</td><td class="align_center">Negative in lesional cells</td></tr><tr><td class="align_left">Bcl-2 (M; 124; DAKO)</td><td class="align_center">Negative in lesional cells</td></tr><tr><td class="align_left">Bcl-6 (M; PG-B6p; DAKO)</td><td class="align_center">Positive in lesional cells</td></tr><tr><td class="align_left">C-myc (RM; Y69; Epitomics)</td><td class="align_center">Focal weak positivity (control is also weak)</td></tr><tr><td class="align_left">Ki- 67 (M; MIB1; DAKO)</td><td class="align_center">&gt;90% positive</td></tr><tr><td class="align_left">TdT (terminal deoxynucleotidyl transferase) (M; SEN28; Vector)</td><td class="align_center">Negative</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Case Reports in Gastrointestinal Medicine

tab1

Table 1

Table 1: Primary Pancreatic Burkitt’s Lymphoma: A Case Report and Review of the Literature 